机构

• 上海药物研究所 [12]
• 西北高原生物研究所 [1]
• 中国科学院大学 [1]
• 海洋研究所 [1]
• 上海生物化学与细胞生... [1]
• 合肥物质科学研究院 [1]
• 更多

采集方式

• OAI收割 [16]
• iSwitch采集 [1]

内容类型

• 期刊论文 [17]

发表日期

• 2024 [1]
• 2022 [1]
• 2021 [1]
• 2020 [1]
• 2019 [2]
• 2017 [1]
• 更多

学科主题

• Cell Biolo... [1]

筛选

浏览/检索结果: 共17条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文  OAI收割 CANCER LETTERS, 2024, 卷号: 582, 页码: 15 作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/07 Acquired resistance  Cancer  NSCLC  JC-010a  SHP2   L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression 期刊论文  OAI收割 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 6, 页码: 14 作者:  Huang, Jing;  Wang, Xiaobo;  Li, Bing;  Shen, Shiyu;  Wang, Ruina   |  收藏  |  浏览/下载：20/0  |  提交时间：2022/08/16 Immunotherapy  Immune Evation  T-Lymphocytes  Translational Medical Research   Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Tao, Zhonghua;  Liu, Jianxia;  Li, Ting;  Xu, Hong;  Chen, Kai   |  收藏  |  浏览/下载：70/0  |  提交时间：2022/01/10 receptor tyrosine kinase  gene fusion  genomic rearrangments  breast cancer  next-generation sequencing   Synthesis and evaluation of new thiourea derivatives as antitumor and antiangiogenic agents 期刊论文  OAI收割 TETRAHEDRON LETTERS, 2020, 卷号: 61, 期号: 40 作者:  Bai, Wenjing;  Ji, Jianxin;  Huang, Qiang;  Wei, Wei   |  收藏  |  浏览/下载：14/0  |  提交时间：2020/11/25 Thiourea derivatives  Antitumor  Antiangiogenesis  RTK inhibitors   Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas 期刊论文  OAI收割 BMC CANCER, 2019, 卷号: 19, 期号: 1, 页码: 13 作者:  Zhang, Qing;  Liu, Jian-He;  Liu, Jing-Li;  Qi, Chun-Ting;  Yan, Lei   |  收藏  |  浏览/下载：65/0  |  提交时间：2020/07/01 Receptor tyrosine kinases (RTKs)  Activation and function  Clear cell renal cell carcinomas (ccRCCs)  Targeted therapy  PDGFR beta  Stroma cells   Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2019, 卷号: 10, 页码: 15 作者:  Jin, Nan;  Bi, Aiwei;  Lan, Xiaojing;  Xu, Jun;  Wang, Xiaomin   |  收藏  |  浏览/下载：32/0  |  提交时间：2020/07/01 Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells 期刊论文  OAI收割 ONCOTARGET, 2017, 卷号: 8, 期号: 3, 页码: 5003-5015 作者:  Song, Qiaoling;  Sun, Xiaoxiao;  Guo, Hui;  Yu, Qiang   |  收藏  |  浏览/下载：19/0  |  提交时间：2019/01/08 receptor tyrosine kinases  AKT  colorectal cancer  drug combination  RAS/RAF   Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 卷号: 85, 页码: 207-214 作者:  Tan, Shaoying;  Han, Kun;  Li, Qiang;  Tong, Linjiang;  Yang, Yiqi   |  收藏  |  浏览/下载：14/0  |  提交时间：2019/01/08 Metal complexes  Naphthalimide  Cyclam  RTK inhibitors  Antiproliferation  Antiangiogenesis   Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming 期刊论文  OAI收割 CELL RESEARCH, 2014, 卷号: 24, 期号: 9, 页码: 1121-1136 作者:  Chen, Guofang;  Xu, Xinxiu;  Zhang, Lihong;  Fu, Yanbin;  Wang, Min   |  收藏  |  浏览/下载：16/0  |  提交时间：2019/01/08 sunitinib  Sutent  embryonic stem cell  self-renewal  iPSC  VEGF  autocrine   Novel 2,4-Diarylanninopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities 期刊论文  OAI收割 ACS MEDICINAL CHEMISTRY LETTERS, 2014, 卷号: 5, 期号: 4, 页码: 304-308 作者:  Liu, Zhiqing;  Ai, Jing;  Peng, Xia;  Song, Zilan;  Wu, Kui   |  收藏  |  浏览/下载：55/0  |  提交时间：2019/01/08 C1-Substituted-N3-benzazepine  c-Met/ALK dual inhibitor  structure repurposing  2,4-diarylaminopyrimidine analogues